The molecular pathophysiology of obesity-driven ECM remodelling or myocardial fibrosis is attributed to hypoxia, inflammation, activation of renin-angiotensin-aldosterone system, TGF-β signalling, and oxidative stress [35]. This evidence concerns the gene TGFB1 and obesity due to melanocortin 4 receptor deficiency.